# Tenax Therapeutics, Inc. (TENX): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Tenax Therapeutics, Inc. (TENX) is 9/100, ranked against 24,000+ stocks in 35 markets (Quality 32, Value 35, Momentum 13, each scored against its sector).

- StockRank: 9/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 32, Value 35, Momentum 13: each a 0-100 percentile within Healthcare.
- Position: #24,163 overall, #2,343 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 1.64 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 133K; 5%+ holders bought USD 6.3M.

Source: https://moatmap.ai/stock/TENX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker